MEXICO CITY (Reuters) -Mexico aims to have developed a vaccine against COVID-19 that could be granted approval for emergency use this year, a senior official said on Tuesday, an outcome that could wean it off unreliable foreign supplies for its slow vaccination program.
The head of the National Council of Science and Technology (Conacyt), Maria Elena Alvarez-Buylla, told a news conference that the vaccine under development could be granted approval in November or December of this year.
Clinical trials with volunteers could begin this month, according to Avimex, the veterinary pharmaceutical company that . . .
